Royal DSM N.V.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
  • Biotechnology

Other Names/Subsidiaries

  • Aland Holding
  • Aland (HK) Holding Limited
  • Amyris Brasil
  • BioCare Copenhagen
  • DSM Biomedical
  • Koninklijke CSK Food Enrichment C.V.
  • Koninklijke DSM N.V.
  • Fortitech
  • Glycom
  • Glycom A/S
  • Kensey Nash
  • Martek Biosciences
  • Tortuga Companhia Zootecnica Agraria
  • Unitech Industries
See more in Biomedtracker

Latest on Royal DSM N.V.

HBW Insight

P&G Ventures Startup Incubator Yields Supplements For Menopause Symptoms

 
• By Eileen Francis

The Kindra line of dietary supplements and personal care products for menopause symptoms is the first brand to leave the Launchpad business incubator funded by Procter & Gamble Co. ’s P&G Ventures st

HBW Insight

Amarin's Asking ITC To Do FDA's Job, Federal Attorneys Tell Supreme Court

 
• By Malcolm Spicer

The basis for Amarin Corp. PLC 's argument that some omega-3 imports are unfair competition for a drug it markets already has been rejected, says the federal government in urging the US Supreme Court

HBW Insight

Omega-3 Firms Parse Amarin's Fair Trade Complaint Into Tariff Act Questions

 
• By Malcolm Spicer

Attorneys representing omega-3 firms parse more finely than the federal government their opposition to Amarin Corp. PLC 's petition to the Supreme Court to hear a complaint that the firms' products a

Medtech Insight

Market Brief: Global Orthobiologics Market Will Reach $2.3Bn By 2023 With Highest Growth In Cartilage Replacement

 
• By Marion Webb

The global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration is expected to reach $2.3bn by 2023, with a compound annual growth rate (CAGR) of 4.0%, according to "